NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626385)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
Comprehensive Profiling by Non-targeted Stable Isotope Tracing Capillary Electrophoresis-Mass Spectrometry NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Comprehensive Profiling by Non-targeted Stable Isotope Tracing Capillary Electrophoresis-Mass Spectrometry Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Mechanisms for Insulin Resistance in Polycystic Ovary Syndrome with metformin therapy: aminoadipic acid, lysine concentrations, and enrichment (part I) NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Mechanisms for Insulin Resistance in Polycystic Ovary Syndrome with metformin therapy: aminoadipic acid, lysine concentrations, and enrichment (part I) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Targeted LC MS of acylcarnitines: TLCMS NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Targeted LC MS of acylcarnitines: TLCMS Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
GC-MS Metabolomics Reproducibility Study NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
GC-MS Metabolomics Reproducibility Study Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
CHEAR Plasma Reference Material Proficiency Test Biocrates NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
CHEAR Plasma Reference Material Proficiency Test Biocrates Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Human serum for a patient with neuropathy being treated with L-serine. NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Human serum for a patient with neuropathy being treated with L-serine. Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
CHEAR Plasma Reference Material Plasma GC-MS NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
CHEAR Plasma Reference Material Plasma GC-MS Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
Establishing the Validity of a Mid-Pregnancy Serum Archive for Novel Studies of Perinatal Outcomes (part VI) NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Establishing the Validity of a Mid-Pregnancy Serum Archive for Novel Studies of Perinatal Outcomes (part VI) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
CHEAR Urine Reference Material Proficiency Test NMR (Part I) NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
CHEAR Urine Reference Material Proficiency Test NMR (Part I) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019
TC and B6 untreated plasma in lupus-prone mice NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
TC and B6 untreated plasma in lupus-prone mice Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Effect of cooling on muscle tissue metabolism (part II) NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Effect of cooling on muscle tissue metabolism (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 24, 2019
Metabolic profiling of identified single cells in Xenopus laevis embryos NIH Common Fund Data Ecosystem (CFDE) FAIR Assessments
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 24, 2019